5397 篇
13910 篇
478030 篇
16306 篇
11769 篇
3941 篇
6548 篇
1253 篇
75650 篇
37902 篇
12167 篇
1665 篇
2867 篇
3421 篇
641 篇
1241 篇
1979 篇
4921 篇
3875 篇
5488 篇
全球孤儿药市场报告(2015-2019年)
Global Orphan Drugs Market 2015-2019
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Overview
Orphan medicines legislation
Orphan medicines centralized procedure in US/EU
Product registration process for orphan drugs in Japan
Orphan drug designations and approvals
Annual cost of orphan drugs
R&D costs for orphan and non-orphan drugs
PART 06: Pipeline snapshot
PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 08: Market segmentation by product
Global biologic orphan drugs market
Global non-biologic orphan drugs market
PART 09: Geographical segmentation
Orphan drugs market in Americas
Orphan drugs market in EMEA
Orphan drugs market in APAC
PART 10: Market drivers
Shorter development timelines
Assistance from regulatory bodies
Incentives for developing orphan drugs
High return on investment
Exemption from pricing constraints
PART 11: Impact of drivers
PART 12: Market challenges
High cost of drug development
Decreased investment in marketing
Complications in conducting clinical trials
Unknown pathophysiology
Adverse policies of FDA
PART 13: Impact of drivers and challenges
PART 14: Market trends
Increased focus on biological drugs
Growing awareness of orphan drugs
Channel marketing strategy
Expansion of business
Entry into untapped market
PART 15: Vendor landscape
Competitive scenario
Major vendors 2014
Worldwide orphan drug sales revenue: Top
companies 2013
Top 10 orphan drugs in US 2014
Other prominent vendors
PART 16: Key vendor analysis
BMS
Celgene
Novartis
Pfizer
PART 17: Appendix
List of abbreviations
PART 18: Explore Technavio